NT_1170x120_1-11-18

Lovell Drugs

Lovell Drugs signs supply deal for medicinal cannabis

Lovell Drugs signs supply deal for medicinal cannabis

TORONTO — Canada’s Lovell Drugs has entered into a definitive agreement with Maricann Group Inc. to be the exclusive supplier of medicinal cannabis to its pharmacies. Maricann said that Lovell has begun dispensing medical marijuana to its patients, registering and filling its first medicinal cannabis prescription registered and fulfilled on Dec. 1. The drug chain

Lovell Drugs enlists Maricann to supply medicinal cannabis

Lovell Drugs enlists Maricann to supply medicinal cannabis

TORONTO — Ontario pharmacy chain Lovell Drugs has signed a letter of intent with Maricann Group Inc. to be its exclusive supplier of medicinal cannabis. Under the planned four-year pact, the companies would work together to develop processes to facilitate the distribution and sale of Maricann’s medicinal cannabis to patients through Lovell Drugs retail pharmacies,

Lovell Drugs to offer skin cancer scans

Lovell Drugs to offer skin cancer scans

MISSISSAUGA, Ontario — Skin cancer screening is coming to Lovell Drugs through an agreement with MedX Health Corp. and the Ontario Telemedicine Network (OTN). Plans call for the 12-store Canadian drug chain to offer in-pharmacy scanning of skin moles and lesions at its locations in Oshawa and Whitby, Ontario. MedX said the service will use